Santosh Saraf MD

PubMed

• Steady-State Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity Predicts Low Platelet Count at Hospitalization for Sickle Cell Disease Vaso-Occlusive Episodes.
  Xu Zhang, Binal N Shah, Jin Han, José A López, Dominic W Chung
  American Journal of Hematology. 2025-05-01
• Development of Polygenic Risk Score for Persistent Albuminuria in Children and Adults With Sickle Cell Anemia.
  Rima S Zahr, Guolian Kang, Xu Zhang, Sara R Rashkin, Csaba P Kovesdy
  American Journal of Hematology. 2025-04-05
• Systemic lupus erythematosus-associated autoantibodies in sickle cell disease: Spontaneous emergence in a patient and in transgenic sickle mice.
  Urshita Sinha, Suman Setty, Céleste Pilon, Julia J Brown, Maria Armila Ruiz
  British Journal of Haematology. 2025-04-01

Abstracts/Posters

• Phase 1 Single (SAD) and Multiple Ascending Dose (MAD) Studies of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of FT-4202, an Allosteric A...
  Santosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease
  Santosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Risk Factors for Kidney Disease in Hb SC and Hb S_+-Thalassemia Sickle Cell Disease
  Santosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Biomarkers of Cardiopulmonary, Renal, and Liver Dysfunction in an Adult Sickle Cell Disease Cohort
  Santosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Progression of Albuminuria in Sickle Cell Anemia: A Multicenter, Longitudinal Study
  Santosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Thrombomodulin and Endothelial Dysfunction in Sickle Cell Anemia
  Santosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Effect of Crizanlizumab Plus Standard of Care (SoC) Versus Soc Alone on Renal Function in Patients with Sickle Cell Disease and Chronic Kidney Disease: A Randomize...
  Santosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Manifestations of Reduced Kidney Function Occur at a Higher Estimated Glomerular Filtration Rate in Sickle Cell Anemia
  Santosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Manifestations of Reduced Kidney Function Occur at a Higher Estimated Glomerular Filtration Rate in Sickle Cell Anemia 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Laboratory and Translational Hematology 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Regulatory Genetic Variation at the S100B Gene Associates with Vaso-Occlusive Manifestations in Sickle Cell Disease 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Clinical, Laboratory, and Genetic Risk Factors for Thrombosis in Sickle Cell Disease 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Cancer Incidence in Sickle Cell Disease:an Institutional Experience 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all